CTVA Price Prediction Next Week
Based on the provided data and technical analysis, here is the price prediction for CTVA for the next trading week:
Technical Analysis
- Current price: $63.96 (as of Jan 24, 2025 close)
- RSI(14) at 71.05 indicates overbought conditions
- MACD is positive at 1.35, showing bullish momentum
- Stock is trading above both 20-day SMA ($59.28) and 200-day SMA ($56.28)
Key Support & Resistance Levels
- Fibonacci Resistance: $63.85 (R1), $65.89 (R2)
- Fibonacci Support: $57.25 (S1), $55.21 (S2)
- Key pivot point: $60.55
News Impact
- Upcoming Q4 earnings release on February 5, 2025 with expected EPS of $0.35, up 133.3% YoY
- Strong analyst consensus with "Strong Buy" rating and average price target of $67.38
- Recent institutional activity shows mixed sentiment with 483 institutions adding positions while 582 reducing
Price Target for Next Week Based on technical indicators and news sentiment:
- Bullish scenario (40% probability): $65.50-66.00
- Base case (50% probability): $63.00-64.50
- Bearish scenario (10% probability): $61.50-62.50
Trading Recommendation HOLD/ACCUMULATE position. While technical indicators suggest overbought conditions, strong fundamentals and upcoming earnings could provide upside momentum. However, wait for potential pullback toward $62.50-$63.00 range before adding new positions.
CTVA Similar Chart Price Prediction
The price of CTVA is predicted to go up 2.44%, based on the high correlation periods with DSGX. The similarity of these two price pattern on the periods is 97.78%.
CTVA
DSGX
Up: 2.44%Similarity: 97.78%
CTVA Revenue Forecast
CTVA EPS Forecast
CTVA FAQs
What is revenue forecast for next quarter？
What is eps forecast for next quarter？
CTVA VS S&P500
Corteva's profits will see a boost from the expiration of a $1 billion annual royalty payment to Bayer in 2023.
Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.
Corteva's strong pipeline of patented crop protection chemicals will drive profits and margins higher as the company expands its proportion of sales from patented and differentiated crop protection products.
CTVA Analyst's Forecast
Benjamin Theurer
Barclays
Hold
Price Target
$62 → $64
Upside
+1.39%
Barclays analyst Benjamin Theurer raised the firm's price target on Corteva to $64 from $62 and keeps an Equal Weight rating on the shares. Entering 2025, the firm is more optimistic about crop protection and maintains a positive outlook on diversified international protein names and ingredients. In contrast, Barclays adds caution to its grain processor coverage and adjusted ratings in fertilizer given the recent run-up in share prices. It recognizes the strength in potash volumes in 2024 did not bring stock appreciation for the major potash players.
Joshua Spector
UBS
Strong Buy
Price Target
$74 → $73
Upside
+27.87%
Aleksey Yefremov
Keybanc
Buy
Price Target
$69 → $68
Upside
+19.11%